Considerations on COM(2020)17 - EU position in 63rd Commission Narcotic Drugs on addition to list of substances in Table UN Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
| dossier | COM(2020)17 - EU position in 63rd Commission Narcotic Drugs on addition to list of substances in Table UN Convention against Illicit ... |
|---|---|
| document | COM(2020)17  |
| date | February 27, 2020 |
| (2) | Pursuant to Article 12(2) to (7) of the Convention, substances may be added to the Tables of the Convention in which drug precursors are listed. |
| (3) | During its sixty-third session from 2 to 6 March 2020 in Vienna, the Commission on Narcotic Drugs is to take a decision on the addition of one substance to Table I of the Convention. |
| (4) | It is appropriate to establish the position to be taken on the Union’s behalf in the Commission on Narcotic Drugs, as the decision will have legal effect in the Union and will be capable of decisively influencing the content of Union law, namely Council Regulation (EC) No 111/2005 (2) and Regulation (EC) No 273/2004 of the European Parliament and of the Council (3). |
| (5) | According to the assessment of the International Narcotics Control Board, the substance methyl alpha-phenylacetoacetate (MAPA) is frequently used in the illicit manufacture of amphetamine and methamphetamine. There is evidence that the volume and extent of the illicit manufacture of these narcotic drugs and psychotropic substances poses serious public health or social problems so as to warrant the placing of methyl alpha-phenylacetoacetate (MAPA) under international control. The illegal manufacture of amphetamine and methamphetamine causes significant public health and social problems in the Union. Incidents relating to the trafficking of methyl alpha-phenylacetoacetate (MAPA) are increasing in both amount and frequency, and organised crime groups in the Union are illegally exporting amphetamine and methamphetamine to third countries. |
| (6) | The Union’s position should be expressed by the Member States of the Union that are members of the Commission on Narcotic Drugs, |